Skip to main content
SpringerLink
Log in

Molekularbiologie und Genetik urogenitaler Tumoren

  • Chapter
Uroonkologie

  • 18 Accesses

Zusammenfassung

Die raschen Fortschritte in der Molekular- bzw. Zellbiologie haben unser Verständnis über Entstehung und Progression maligner Tumoren revolutioniert. Obwohl bereits 1914 der deutsche Zoologe Theodor Boveri chromosomale Veränderungen in Krebszellen beschrieben hatte, haben erst die in den letzten Jahren entwickelten Methoden der modernen Molekularbiologie die Entdeckung einiger der zugrundliegenden genetischen Alterationen möglich gemacht. In den folgenden Abschnitten werden diese für die häufigen urologischen Organtumoren zusammengefaßt. Dabei sollen nicht nur die pathogenetisch bedeutsamen Veränderungen an Chromosomen bzw. Genen beschrieben werden. Es soll darüber hinaus versucht werden aufzuzeigen, welche Ergebnisse der Grundlagenforschung künftig Einfluß auf Diagnostik und Therapie urogenitaler Tumoren haben könnten.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Almon E, Goldfinger N, Kapon A, Schwartz D, Levine AJ, Rotter V (1993) Testicular tissue-specific expression of the p53 suppressor gene. Dev Biol 156:107–116

    PubMed  CAS  Google Scholar 

  • Anglard P, Tory K, Brauch H et al. (1991) Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 51:1071–1077

    PubMed  CAS  Google Scholar 

  • Anglard P, Tranhan E, Liu S et al. (1992) Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res 52:348–356

    PubMed  CAS  Google Scholar 

  • Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M (1992) Presence of ras oncogene mutations and human papilloma virus DNA in human prostate carcinoma. Cancer Res 52: 5991–5996

    PubMed  CAS  Google Scholar 

  • Arason A, Barkardottir RB, Egilsson V (1993) Linkage analysis of chromosome-i7q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic-cancer. Am J Hum Genet 52:711–717

    PubMed  CAS  Google Scholar 

  • Atkin NB, Baker MC (1985 a) Chromosome study of five cancers of the prostate. Hum Genet 70:359–364

    Google Scholar 

  • Atkin NB, Baker MC (1985 b) Chromosome 10 deletion in carcinoma of the prostate. New Engl J Med 312:315

    Google Scholar 

  • Atlas I, Mendelsohn J, Baselga J, Fair WR, Masui H, Kumar R (1992) Growth regulation of human renal carcinoma cells: Role of transforming growth factor α. Cancer Res 52:3335–3339

    PubMed  CAS  Google Scholar 

  • Barnes R, Masood S, Barker E et al. (1991) Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am J Pathol 139:245–250

    PubMed  CAS  Google Scholar 

  • Bártek J, Bártková J, Vojtešek B et al. (1991) Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699–1703

    PubMed  Google Scholar 

  • Bártková J, Bártek J, Lukaš J et al. (1991) P53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer 49:196–202

    PubMed  Google Scholar 

  • Berger MS, Greenfield C, Gullick WJ et al. (1987) Evaluation of epidermal growth factor receptors in bladder tumours. Br J Cancer 56:533–537

    PubMed  CAS  Google Scholar 

  • Bergerheim U, Nordenskjöld M, Collins P (1989) Deletion mapping in human renal cell carcinoma. Cancer Res 49:1390–1396

    PubMed  CAS  Google Scholar 

  • Bérubé NG, Speevak MD, Chevrette M (1994) Suppression of tumorigenicity of human prostate cancer cells by introduction of human chromosom del(12)(q 13). Cancer Res 54:3077–3081

    PubMed  Google Scholar 

  • Bevilacqua G, Sobel ME, Liotta LA, Steeg PS (1989) Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histo-pathological indicators of high metastatic potential. Cancer Res 49:5185–5190

    PubMed  CAS  Google Scholar 

  • Bookstein R, Shew JY, Chen P-L, Scully P, Lee W-H (1990a) Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712–715

    PubMed  CAS  Google Scholar 

  • Bookstein R, Rio P, Madreperla S, Hong F, Allred C, Grizzle WE, Lee WH (1990 b) Promotor deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87:7762–7766

    PubMed  CAS  Google Scholar 

  • Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC (1993) p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res 53:3369–3373

    PubMed  CAS  Google Scholar 

  • Bosl GJ, Dmitrovsky E, Reuter VE et al. (1989) Isochromosome of chromosome 12: Clinically useful marker for male germ cell tumors. J Natl Cancer Inst 81:1874–1878

    PubMed  CAS  Google Scholar 

  • Bosl GJ, Ilson DH, Rodriguez E, Motzer RJ, Reuter VE, Chaganti RSK (1994) Clinical relevance of the i (12p) marker chromosome in germ cell tumors. J Natl Cancer Inst 86:349–355

    PubMed  CAS  Google Scholar 

  • Bova GS, Carter BS, Bussemakers MJG et al. (1993) Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869–3873

    PubMed  CAS  Google Scholar 

  • Brachmann R, Lidquist PB, Nagashima M et al. (1989) Transmembrane TGF-α precursors activate EGF/TGF-α receptors. Cell 56:691–700

    PubMed  CAS  Google Scholar 

  • Brewster SF, Browne S, and Brown KW (1994) Somatic allelic loss at the DCC, APC, nm23-H1 and P53 tumor suppressor gene loci in human prostatic carcinoma. J Urol 151:1073–1077

    PubMed  CAS  Google Scholar 

  • Bringuier PP, Umbas R, Schaafsma HE, Karthaus HFM, Debruyne FMJ, Schalken JA (1993) Decreased E-Cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res. 53:3241–3245

    PubMed  CAS  Google Scholar 

  • Brooks JD, Bova GS, Isaacs WB (1995) Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas. Prostate 26:35–39

    PubMed  CAS  Google Scholar 

  • Bussemakers MJC, van Morselaar RJA, Giroldi L et al. (1992) Decreased expression of E-Cadherin in the progression of rat prostatic cancer. Cancer Res 52:2916–2922

    PubMed  CAS  Google Scholar 

  • Buttyan R, Sawczuk IS, Benson MC, Siegal JD, Olsson CA (1987) Enhanced expression of the c-myc protooncogene in high-grade prostate cancers. Prostate 11:327–337

    PubMed  CAS  Google Scholar 

  • Cabrera G, Bass C, Elgavish A et al. (1995) Highly efficient gene transduction of bladder epithelium mediated by a recombinant adenoviral vector. Urol Res 23:277A

    Google Scholar 

  • Cairns P, Proctor AJ, Knowles MA (1991) Loss of heterozygosity at the Rb locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 6:2305–2309

    PubMed  CAS  Google Scholar 

  • Cairns P, Shaw ME, Knowles MA (1993) Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res 53:1230–1232

    PubMed  CAS  Google Scholar 

  • Cairns P, Mao L, Merlo et al. (1994) Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415–416

    PubMed  CAS  Google Scholar 

  • Cama C, Olsson CA, Raffo AJ et al. (1995) Molecular staging of prostate cancer. IL A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J Urol 153: 1373–1378

    PubMed  CAS  Google Scholar 

  • Carter BS, Ewing CM, Ward WS et al. (1990 a) Allelic loss of chromosomes 16 q and 10 q in human prostate cancer. Proc Natl Acad Sci USA 87:8751–8755

    PubMed  CAS  Google Scholar 

  • Carter BS, Epstein JI, Isaacs WB (1990 b) Ras gene mutations in human prostate cancer. Cancer Res 50:6830–6832

    Google Scholar 

  • Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH (1995) Mapping of regions of physical deletion on chromosome 16 q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 153:249–254

    PubMed  CAS  Google Scholar 

  • Clairmont A, Ebert T, Weber H et al. (1994) Lowered amounts of the tissue-specific transcription factor LFB1 (HNF1) correlate with decreased levels of glutathione S-transferase α messenger RNA in human renal cell carcinoma. CancerRes 54:1319–1323

    CAS  Google Scholar 

  • Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, Brown RS (1979) Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 301:592–595

    PubMed  CAS  Google Scholar 

  • Connolly JM, Rose DP (1991) Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19:173–180

    PubMed  CAS  Google Scholar 

  • Connor J, Bannerji R, Saito S, Heston W, Fair W, Gilboa E (1993) Regression of bladder tumors in mice with Interleukin 2 gene modified tumor cells. J Exp Med 177:1127–1134

    PubMed  CAS  Google Scholar 

  • Cordon-Cardo C, Wartinger D, Petrylak D et al. (1992) Altered expression of the retinoblastoma gene product is a prognostic indicator in bladder cancer. J Natl Cancer Inst 84:1251–1256

    PubMed  CAS  Google Scholar 

  • Cordon-Cardo C, Dalbagni G, Saez GT et al. (1994) p53 mutations in human bladder cancer: geno-typic versus phenotypic patterns. Int J Cancer 56:347–353

    PubMed  CAS  Google Scholar 

  • Culig Z, Hobisch A, Cronauer MV et al. (1993) Mutant androgen receptor detected in an advanced stage of prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 7:1541–1550

    PubMed  CAS  Google Scholar 

  • Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550–1552

    PubMed  CAS  Google Scholar 

  • Davies P, Eaton CL, France TD, Phillips ME (1988) Growth factor receptors and oncogene expression in prostate cells. Am J Clin Oncol 11 [Suppl 2]:S1–7

    PubMed  Google Scholar 

  • Davies P, Eaton CL (1989) Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate. Prostate 14:123–132

    PubMed  CAS  Google Scholar 

  • Deguchi T, Doi T, Ehara H et al. (1993) Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 53:5350–5354

    PubMed  CAS  Google Scholar 

  • Dinjens WNM, van der Weiden MM, Schroeder FH, Bosman FT, Trapman J (1994) Frequency and characterization of p 53 mutations in primary and metastatic human prostate cancer. Int J Cancer 56:630–633

    PubMed  CAS  Google Scholar 

  • Dong J-T, Lamb PW, Rinker-Schaeffer CW et al. (1995) KAI1, a metastasis suppressor gene for prostate cancer on human chromosome up 11.2. Science 268:884–886

    PubMed  CAS  Google Scholar 

  • Dranoff G, Jaffee E, Lazenby A et al. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci 90:3539–3543

    PubMed  CAS  Google Scholar 

  • Effert PJ, Neubauer A, Walther PJ, Liu ET (1992) Alterations of the p 53 gene are associated with the progression of a human prostate carcinoma. J Urol 147:789–793

    PubMed  CAS  Google Scholar 

  • Effert PJ, McCoy RH, Walther PJ, Liu ET (1993) p53 gene alterations in human prostate carcinoma. J Urol 150:257–261

    Google Scholar 

  • Eickelmann P, Ebert T, Warskulat U, Schulz WA, Sies H (1994) Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases a and π in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogenesis 15:219–225

    PubMed  CAS  Google Scholar 

  • Emmert-Buck MR, Vocke CD, Pozzatti RO et al. (1995) Allelic loss on chromosome 8 p 12–21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 55:2959–2962

    PubMed  CAS  Google Scholar 

  • Esrig D, Elmajian D, Groshen S et al. (1994) Accumulation of nuclear p 53 and tumor progression in bladder cancer. New Engl J Med 331:1259–1264

    PubMed  CAS  Google Scholar 

  • Fan K (1988) Heterogenous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of p21 protein as a predictor for bone metastasis. J Urol 139:318

    PubMed  CAS  Google Scholar 

  • Fearon ER, Feinberg AP, Hamilton SH, Vogelstein B (1985) Loss of genes on the short arm of chromosome 11 in bladder cancer. Nature 318:377–380

    PubMed  CAS  Google Scholar 

  • Fishel R, Lescoe MK, Rao MRS et al. (1993) The human mutator gene homolog MSH 2 and ist association with hereditary nonpolyposis colon cancer. Cell 75:1027–1038

    PubMed  CAS  Google Scholar 

  • Fleischhacker M, Strohmeyer T, Imai Y, Slamon DJ, Koeffler HP (1994) Mutations of the p 53 gene are not detectable in human testicular tumors. Mod Pathol 7:435–439

    PubMed  CAS  Google Scholar 

  • Fleming WH, Hamel A, MacDonald R et al. (1986) Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia. Cancer Res 46:1535–1538

    PubMed  CAS  Google Scholar 

  • Fowler JE Jr, Lau JLT, Ghosh L, Mills SE, Mounzer A (1988) Epidermal growth factor and prostatic carcinoma: an immunhistochemical study. J Urol 139:857–861

    PubMed  Google Scholar 

  • Fox SB, Persad RA, Royds J, Kore RN, Silcocks PB, Collins CC (1993) P53 and c-myc expression in stage Ai prostatic adenocarcinoma: useful prognostic determinants? J Urol 150:490–494

    PubMed  CAS  Google Scholar 

  • Freeman MR, Washecka R, Chung LWK (1989) Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers. Cancer Res 49:6221–6225

    PubMed  CAS  Google Scholar 

  • Frixen UH, Behrens J, Sachs M et al. (1991) E-Cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173–185

    PubMed  CAS  Google Scholar 

  • Fujimoto K, Yamada Y, Okajima E et al. (1992) Frequent association of p53 gene mutations in invasive bladder cancer. Cancer Res 52:1393–1398

    PubMed  CAS  Google Scholar 

  • Fujita J, Srivastava SK, Kraus MH (1985) Frequency of molecular alterations affecting ras protoon-cogenes in human urinary tract tumors. Proc Natl Acad Sci 82:3849–3853

    PubMed  CAS  Google Scholar 

  • Fung Y-KT, T’Ang A, Murphree AL et al. (1993) The Rb gene suppresses the growth of normal cells. Oncogene 8:2659–2672

    PubMed  CAS  Google Scholar 

  • Gaddipati JP, McLeod DG, Heidenberg HB et al. (1994) Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res 54:2861–2864

    PubMed  CAS  Google Scholar 

  • Ganguly S, Murty VV, Samaniego F, Reuter VE, Bosl GJ, Chaganti RS (1990) Detection of preferential NRAS mutations in human male germ cell tumors by polymerase chain reaction. Genes Chromosomes Cancer 1:228–232

    PubMed  CAS  Google Scholar 

  • Gao X, Honn KV, Grignon D, Sakr W, Chen YQ (1993) Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res 53:2723–2727

    PubMed  CAS  Google Scholar 

  • Gao X, Zacharek A, Salkowski A et al. (1995) Loss of heterozygosity of the BRCA1 and other loci on chromosome 17 q in human prostate cancer. Cancer Res 55:1002–1005

    PubMed  CAS  Google Scholar 

  • Gastl G, Finstad CL, Guarini A et al. (1992) Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer Res 52:6229–6236

    PubMed  CAS  Google Scholar 

  • Gibas Z, Prout GR Jr, Connolly JG, Pontes JE, Sandberg AA (1984) Nonrandom chromosomal changer in transitional cell carcinoma of the bladder. Cancer Res 44:1257–1264

    PubMed  CAS  Google Scholar 

  • Gibas Z, Pontes JE, Sandberg AA (1985) Chromosome rearrangements in a metastatic adenocarcinoma of the prostate. Cancer Genet Cytogenet 16:301–304

    PubMed  CAS  Google Scholar 

  • Gibas Z, Prout GR, Pontes JE, Connolly JG, Sandberg AA (1986) A possible specific chromosome change in transitional cell carcinoma of the bladder. Cancer Genet Cytogenet 19:229–238

    PubMed  CAS  Google Scholar 

  • Gnarra JR, Tory K, Weng Y et al. (1994) Mutations of the VHL tumour suppressor gene in renal cell carcinoma. Nature Gen 7:85–90

    CAS  Google Scholar 

  • Golumbek PT, Lazenby AJ, Levitsky HI et al. (1991) Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254:713–716

    PubMed  CAS  Google Scholar 

  • Gonzalez-Zulueta M, Ruppert JM, Tokino K et al. (1993) Microsatellite instability in bladder cancer. Cancer Res 53:5620–5623

    PubMed  CAS  Google Scholar 

  • Goodrich DW, Chen Y, Scully P, Lee H-W (1992) Expression of the retinoblastoma gene product in bladder carcinoma cells associates with a low frequency of tumor formation. Cancer Res 52:1968–1973

    PubMed  CAS  Google Scholar 

  • Gore ME, Collins MK (1994) Gene therapy for cancer. Eur J Cancer 30A: 1047–1049

    PubMed  CAS  Google Scholar 

  • Goustin AS, Leof EB, Shipley GD, Moses HL (1986) Growth factors and cancer. Cancer Res 46:1015–1029

    PubMed  CAS  Google Scholar 

  • Grimm M-O, Jürgens B, Schulz WA, Decken K, Makri D, Schmitz-Dräger BJ (1995) Inactivation of tumor suppressor genes and deregulation of the c-myc gene in urothelial cancer cell lines. Urol Res 23:293–300

    PubMed  CAS  Google Scholar 

  • Gumerlock PH, Poonamallee UR, Meyers FJ, deVere White RW (1991) Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res 51:1632–1637

    PubMed  CAS  Google Scholar 

  • Habuchi T, Ogawa O, Kakehi Y et al. (1992) Allelic loss of chromosome 17p in urothelial cancer: strong association with invasive phenotype. J Urol 148:1595–1599

    PubMed  CAS  Google Scholar 

  • Habuchi T, Ogawa O, Kakehi et al. (1993 a) Accumulated allelic losses in the development of invasive urothelial cancer. Int J Cancer 53:579–584

    Google Scholar 

  • Habuchi T, Takahashi R, Yamada H et al. (1993 b) Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 342:1087–1088

    Google Scholar 

  • Haugen A, Ryberg D, Hansteen I-L, Amstad P (1990) Neoplastic transformation of a human kidney epithelial cell line transfected with v-Ha-ras oncogene. Int J Cancer 45:572–577

    PubMed  CAS  Google Scholar 

  • Haut M, Steeg PS, Willson JKV, Markowitz SD (1991) Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst 83:712–716

    PubMed  CAS  Google Scholar 

  • Horowitz JM, Yandell DW, Park S-H et al. (1989) Point mutational inactivation of the retinoblastoma antioncogene. Science 243:937–940

    PubMed  CAS  Google Scholar 

  • Horowitz JM, Park S-H, Bogenmann E et al. (1990) Frequent inactivation of the retinoblastoma antioncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci 87:2775–2779

    PubMed  CAS  Google Scholar 

  • Hosoe S, Brauch H, Latif F et al. (1990) Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics 8:634–640

    PubMed  CAS  Google Scholar 

  • Isaacs WB, Carter BS, Ewing CM (1991) Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p 53 alleles. Cancer Res 51:4716–4720

    PubMed  CAS  Google Scholar 

  • Isaacs WB, Bova GS, Morton RA, Bussemakers MJG, Brooks JD, Ewing CM (1994) Molecular biology of prostate Cancer. Sem Oncol 21:514–521

    CAS  Google Scholar 

  • Ishikawa J, Xu H-J, Hu S-X et al. (1991) Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 51:5736–5743

    PubMed  CAS  Google Scholar 

  • Ichikawa T, Ichikawa Y, Dong J et al. (1992) Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 52:3486–3490

    PubMed  CAS  Google Scholar 

  • Israeli RS, Miller WH, Su SL et al. (1994) Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: Comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54:6306–6310

    PubMed  CAS  Google Scholar 

  • Israeli RS, Miller WH Jr, Su SL et al. (1995) Sensitive detection of prostatic hematogenous tumor cell dissemination using prostatic specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. J Urol 153:573–577

    PubMed  CAS  Google Scholar 

  • Kai M, Arakawa H, Sugimoto Y, Murata Y, Ogawa M, Nakamura Y (1995) Infrequent somatic mutation of the MTS1 gene in primary bladder carcinomas. Jpn J Cancer Res 86:249–251

    PubMed  CAS  Google Scholar 

  • Kamb A, Gruis NA, Weaver Feldhaus J et al. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436–440

    PubMed  CAS  Google Scholar 

  • Katz AE, Olsson CA, Raffo AJ et al. (1994) Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43:765–775

    PubMed  CAS  Google Scholar 

  • Keen AJ, Knowles MA (1994) Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene 9:2083–2088

    PubMed  CAS  Google Scholar 

  • Kellens RE (1993) Gene amplification in mammalian cells. A comprehensive guide. Marcel Dekker, New York

    Google Scholar 

  • Kessel AG van, Suijkerbuijk RF, Sinke RJ, Looijenga L, Oosterhuis JW, de Jong B (1993) Molecular cytogenetics of human germ cell tumours: i(i2p) and related chromosomal anomalies. Eur Urol 23:23–29

    Google Scholar 

  • Klocker H, Culig Z, Hobisch A, Cato ACB, Bartsch G (1994) Androgen receptor alterations in prostatic carcinoma. Prostate 25:266–273

    PubMed  CAS  Google Scholar 

  • Knowles MA, Williamson M (1993) Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing. Cancer Res 53:133–139

    PubMed  CAS  Google Scholar 

  • Konishi N, Enomoto T, Buzard G, Ohshima M, Ward JM, Rice JM (1992) K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men. Cancer 69:2293–2299

    PubMed  CAS  Google Scholar 

  • Kovacs G (1993) Molekularzytogenetische Aspekte der Entstehung und Progredienz von Nieren-zellkarzinomen. Immuntherapie in der Uroonkologie. Springer, Berlin Heidelberg New York Tokyo, S 145–150

    Google Scholar 

  • Kovacs G, Erlandsson R, Boldog F et al. (1988) Consistent chromosome 3 p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci 85:1571–1575

    PubMed  CAS  Google Scholar 

  • Kovacs G, Kung HF (1991) Nonhomologous chromatid exchange in hereditary and sporadic renal cell carcinomas. Proc Natl Acad Sci 88:194–198

    PubMed  CAS  Google Scholar 

  • Kuczyk MA, Serth J, Bokemeyer C et al. (1994) Overexpression of the p 53 oncoprotein in carcinoma in situ of the testis. Pathol Res Pract 190:993–998

    PubMed  CAS  Google Scholar 

  • Kuczyk MA, Serth J, Bokemeyer C, Jonas U (1995) Expression von c-kit und Stem Cell Factor (SCF) an Hodentumoren und Hodentumorzellinien. Urologe A [Supppl 1]: S118 (astract)

    Google Scholar 

  • Kunimi K, Bergerheim US, Larsson IL, Ekman P, Collins VP (1991) Allelotyping of human prostatic adenocarcinoma. Genomics 11:530–536

    PubMed  CAS  Google Scholar 

  • Lacombe ML, Sastre-Garau X, Lascu et al. (1991) Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours. Eur J Cancer 27:1302–1307

    PubMed  CAS  Google Scholar 

  • Latif F, Tory K, Gnarra J et al. (1993) Identification of the von Hippel-Lindau tumor suppressor gene. Science 260:1317–1320

    PubMed  CAS  Google Scholar 

  • Latil A, Baron JC, Cussenot O et al. (1994) Oncogene amplifications in early-stage human prostate carcinomas. Int J Cancer 59:637–638

    PubMed  CAS  Google Scholar 

  • Leach NS, Nicolaides NC, Papadopoulos N et al. (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215–1225

    PubMed  CAS  Google Scholar 

  • Li FP, Decker HJH, Zbar B et al. (1993) Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3; 8 translocation. Ann Intern Med 118:106–111

    PubMed  CAS  Google Scholar 

  • Linnenbach AJ, Robbins SL, Seng BA, Tomaszewski JE, Pressler LB, Malkowicz SB (1994) Urothelial carcinogenesis. Science 367:419–420

    CAS  Google Scholar 

  • Lipponen PK (1993) Over-expression of p53 nuclear oncoprotein in transitional-call bladder cancer and its prognostic value. Int J Cancer 53:365–370

    PubMed  CAS  Google Scholar 

  • Logothetis CJ, Xu H-J, Ro JY, Hu S-X, Sahin A, Ordonez N, Benedict WF (1992) Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 84:1256–1261

    PubMed  CAS  Google Scholar 

  • Lundgren R Kristoffersson U, Heim S, Mandahl N, Mitelman F (1988) Multiple structural chromosome rearrangements, including del(7q) and del (10 q), in an adenocarcinoma of the prostate. Cancer Genet Cytogenet 35:103–108

    PubMed  CAS  Google Scholar 

  • Lynch HT, Smyrk TC, Watson P et al. (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104: 1535–1549

    PubMed  CAS  Google Scholar 

  • MacGrogan D, Levy A, Bostwick DG, Wagner M, Wells D, Bookstein R (1994) Loss of chromosome arm 8 p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromsom Cancer 10:151–159

    CAS  Google Scholar 

  • Maddy SQ, Chisholm GD, Busuttil A, Habib FK (1989) Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumor. Br J Cancer 60: 41–44

    PubMed  CAS  Google Scholar 

  • Makri D, Schulz WA, Grimm M-O, Schmitz-Dräger BJ (1995) Rapid killing of urothelial carcinoma cells by wild-type p53. Int J Oncol 7:637–641

    PubMed  CAS  Google Scholar 

  • Marshall RS, Paterson MC, Rauth AM (1991) DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer prone family. Carcinogenesis 12:1175–1180

    PubMed  CAS  Google Scholar 

  • Marx J (1994) New tumor suppressor may rival p53. Science 264:344–345

    PubMed  CAS  Google Scholar 

  • McCann A, Dervan PA, Guillick WJ, Carney DN (1989) c-erbB-2 oncoprotein expression in malignant and non-malignant tissues (abstract). Proc Am Assoc Cancer Res 30:914

    Google Scholar 

  • Massenkeil G, Oberhuber H, Hailemariam S et al. (1994) p53 mutations and loss of heterozygosity on chromosomes 8p, 16 q, 17 p, and 18 q are confined to advanced prostate cancer. Anticancer Res 14:2785–2790

    PubMed  CAS  Google Scholar 

  • Messing EM (1990) Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 50:2530–2537

    PubMed  CAS  Google Scholar 

  • Mickisch GH, Schroeder FH (1994) From laboratory expertise to clinical practice: multidrug-resistance-based gene therapy becomes available for urologists. World J Urol 12:104–111

    PubMed  CAS  Google Scholar 

  • Miyao N, Tsai YC, Lerner SP et al. (1993) Role of chromosome 9 in bladder cancer. Cancer Res 53:4066–4070

    PubMed  CAS  Google Scholar 

  • Moody DB, Robinson JC, Ewing CM, Lazenby AJ, Isaacs WB (1994) Interleukin-2 transfected prostate cancer cells generate a local antitumor effect in vivo. Prostate 24:244–251

    PubMed  CAS  Google Scholar 

  • Moolenar WH, Rob JA, Tertoolen LGJ, de Laat SW (1986) The epidermal growth factor induced signal in A 431 cells. J Biol Chem 261:279–284

    Google Scholar 

  • Moreno JG, Croce CM, Fischer R et al. (1992) Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52:6110–6112

    PubMed  CAS  Google Scholar 

  • Moriyama M, Akiyama T, Yamamoto T et al. (1991) Expression of c-erbB-2 gene product in urinary bladder cancer. J Urol 145:423–427

    PubMed  CAS  Google Scholar 

  • Morris GL, Dodd JG (1990) Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 143:1272–1274

    PubMed  CAS  Google Scholar 

  • Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB (1993) Reduction of E-Cadherin levels and deletion of the a-Catenin gene in human prostate cancer cells. Cancer Res 53:3585–3590

    PubMed  CAS  Google Scholar 

  • Moul JW, Friedrichs PA, Lance RS, Theune SM, Chang EH (1992 a) Infrequent ras oncogene mutations in human prostate cancer. Prostate 20:327–338

    Google Scholar 

  • Moul JW, Theune SM, Chang EH (1992b) Detection of RAS mutations in archival testicular germ cell tumors by polymerase chain reaction and oligonucleotide hybridization. Genes Chromosom Cancer 5:109–118

    PubMed  CAS  Google Scholar 

  • Mulder MP, Keijzer W, Verkerk A et al. (1989) Activated ras genes in human seminoma: evidence for tumor heterogeneity. Oncogene 4:1345–1351

    PubMed  CAS  Google Scholar 

  • Murty VVVS, Houldsworth J, Baldwin S et al. (1992) Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors. Proc Natl Acad Sci 89:11006–11010

    PubMed  CAS  Google Scholar 

  • Murty VVVS, Bosl GJ, Houldsworth J et al. (1994 a) Allelic loss and somatic differentiation in human male germ cell tumors. Oncogene 9:2245–2251

    PubMed  CAS  Google Scholar 

  • Murty VVVS, Li R-G, Houldsworth J et al. (1994 b) Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors. Oncogene 9:3227–3231

    PubMed  CAS  Google Scholar 

  • Mydlo JH, Michaeli J, Cordon-Cardo C, Goldenberg AS, Heston D, Fair W (1989) Expression of transforming growth factor a and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney. Cancer Res 49:3407–3411

    PubMed  CAS  Google Scholar 

  • Myers RB, Oelschlager D, Srivastava S, Grizzle WE (1994) Accumulation of the p 53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas. Prostate 25:243–248

    PubMed  CAS  Google Scholar 

  • Nanus DM, Mentle IR, Motzer RJ, Bander NH, Albino AP (1990) Infrequent ras oncogene point mutations in renal cell carcinoma. J Urol 143:175–178

    PubMed  CAS  Google Scholar 

  • Navone NM, Troncoso P, Pisters LL et al. (1993) p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85:1657–1669

    PubMed  CAS  Google Scholar 

  • Neal DE, Marsh C, Bennett MK et al. (1985) Epidermal growth factor receptors in human bladder cancer: Comparison of invasive and superficial tumours. Lancet 1:366–368

    Google Scholar 

  • Neal DE, Sharpies L, Smith K, Fennelly J, Hall RR, Harris AL (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:1619–1625

    PubMed  CAS  Google Scholar 

  • Newmark JR, Hardy DO, Tonb DC et al. (1992) Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci 89:6319–6323

    PubMed  CAS  Google Scholar 

  • O’Brien SG, Kirkland MA, Goldman JM (1994) Antisense therapy for malignant disease. Eur J Cancer 30A: 1160–1164

    PubMed  Google Scholar 

  • Olumi AF, Tsai YC, Nichols PW et al. (1990) Allelic loss of chromosome 17 p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res 50:7081–7083

    PubMed  CAS  Google Scholar 

  • Otto T, Birchmeier W, Schmidt U, Hinke A, Schipper J, Rübben H, Raz A (1994) Inverse relation of E-Cadherin and Autocrine Motility Factor Receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res 54:3120–3123

    PubMed  CAS  Google Scholar 

  • Pathak S, Strong LC, Ferell RE, Trindade A (1982) Familial renal cell carcinoma with a 3; 11 chromosome translocation limited to tumor cells. Science 217:939–941

    PubMed  CAS  Google Scholar 

  • Peltomäki P, Alfthan O, de la Chapelle A (1991 a) Oncogenes in human testicular cancer: DNA and RNA studies. Br J Cancer 63:851–858

    PubMed  Google Scholar 

  • Peltomäki P, Lothe R, B0rresen A-L, Fossa SD, Brogger A, de la Chapelle A (1991b) Altered dosage of the sex chromosomes in human testicular cancer: a molecular genetic study. Int J Cancer 47:518–522

    PubMed  Google Scholar 

  • Peng H-Q, Hogg D, Malkin D et al. (1993) Mutations of the p53 gene do not occur in testis cancer. Cancer Res 53:3574–3578

    PubMed  CAS  Google Scholar 

  • Peng H-Q, Bailey D, Bronson D, Goss PE, Hogg D (1995) Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res 55:2871–2875

    PubMed  CAS  Google Scholar 

  • Petrides PE, Bock S, Bovens J, Hofmann R, Jakse G (1990) Modulation of pro-epidermal growth factor, pre-transforming growth factor α and epidermal growth factor receptor gene expression in human renal carcinomas. Cancer Res 50:3934–3939

    PubMed  CAS  Google Scholar 

  • Phillips ME, Ferro MA, Smith PJ, Davies P (1987) Intranuclear androgen receptor deployment and protooncogene expression in human diseased prostate. Urol Int 42:115–119

    PubMed  CAS  Google Scholar 

  • Phillips SMA, Morton DG, Lee SJ, Wallace DMA, Neoptelemos JP (1994) Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosome 10 p, 10 q, and 16 q in human prostate cancer. Br J Urol 73:390–395

    PubMed  CAS  Google Scholar 

  • Presti JC, Reuter VE, Galan T, Fair WR, Cordon-Cardo C (1991) Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51:5405–5409

    PubMed  Google Scholar 

  • Presti JC, Reuter VE, Cordon-Cardo C, Mazumdar M, Fair WR, Jhanwar SC (1993) Allelic deletions in renal tumors: Histopathological correlations. Cancer Res 53:5780–5783

    PubMed  CAS  Google Scholar 

  • Quarmby VE, Yarbrough WG, Lubahn DB, French FS, Wilson EM (1990) Autologous down-regulation of androgen receptor messenger ribonucleic acid. Mol Endocrinol 4:22–28

    PubMed  CAS  Google Scholar 

  • Rao JY, Hemstreet III GP, Hurst RE et al. (1993) Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis. Proc Natl Acad Sci 90:8287–8291

    PubMed  CAS  Google Scholar 

  • Reddy EP, Reynolds RK, Santos E, Barbacid M (1982) A point mutation is responsible for the acquisition of transforming properties by the T24 bladder carcinoma oncogene. Nature 300: 149–152

    PubMed  CAS  Google Scholar 

  • Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM (1993) Chromosome 17 p deletions and p53 mutations in renal cell carcinoma. Cancer Res 53:3092–3097

    PubMed  CAS  Google Scholar 

  • Reznikoff CA, Kao C, Messing EM, Newton M, Swaminathan S (1993) A molecular genetic model of human bladder carcinogenesis. Cancer Biol 4:143–152

    CAS  Google Scholar 

  • Rijnders AW, van der Korput JA, van Steenbrugge GJ, Romijn JC, Trapman J (1985) Expression of cellular oncogenes in human prostatic carcinoma cell lines. Biochem Biophys Res Comm 132: 548–554

    PubMed  CAS  Google Scholar 

  • Rodriguez E, Mathew S, Reuter V, Ilson DH, Bosl GJ, Chaganti RSK (1992) Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res 52:2285–2291

    PubMed  CAS  Google Scholar 

  • Rosenberg SA (1994) The gene therapy of cancer. Prev Med 23:624–626

    PubMed  CAS  Google Scholar 

  • Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH (1993) Identification of an NAD(P)H:quino-ne oxidoreductase polymorphism and its association with lung cancer. Proc Am Ass Cancer Res 34:144

    Google Scholar 

  • Ruppert JM, Tokino K, Sidransky D (1993) Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 53:5093–5095

    PubMed  CAS  Google Scholar 

  • Russel SJ (1994) Replicating Vectors for gene therapy of cancer: risks, limitations and prospects. Eur J Cancer 30A: 1165–1171

    Google Scholar 

  • Sadi MV, Barrack ER (1993) Image analysis of androgen receptor immunostaining in metastatic prostate cancer — heterogeneity as a predictor of response to hormonal therapy. Cancer 71:2574–2580

    PubMed  CAS  Google Scholar 

  • Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a guide to methods and applications. Cold Spring Harbour, New York

    Google Scholar 

  • Sanchez Y, El-Naggar A, Pathak S, McNeill Killary A (1994) A tumor suppressor locus within 3 p 14-p12 mediates rapid cell death of renal cell carcinoma in vivo. Proc Natl Acad Sci 91:3383–3387

    PubMed  CAS  Google Scholar 

  • Sanda MG, Ayyagari SR, Jaffee EM et al. (1994) Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol 151:622–628

    PubMed  CAS  Google Scholar 

  • Sandberg AA (1992) Chromosomal abnormalities and related events in prostate cancer. Hum Pathol 23:368–380

    PubMed  CAS  Google Scholar 

  • Sarkis AS, Dalbagni G, Cordon-Cardo C et al. (1993) Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression. J Natl Cancer Inst 85:53–59

    PubMed  CAS  Google Scholar 

  • Sato K, Moriyama M, Mori S et al. (1992) An immunhistologic evaluation of c-erbB-2 gene product in patients with bladder carcinoma. Cancer 70:2493–2498

    PubMed  CAS  Google Scholar 

  • Schenkman NS, Sesterhenn IA, Washington L et al. (1995) Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors. J Urol 154:617–621

    PubMed  CAS  Google Scholar 

  • Scher HI, Kelly WK (1993) Flutamide withdrawal syndrome: Its impact on clinical trials in hormone refractory prostate cancer. J Clin Oncol 11:1566–1572

    PubMed  CAS  Google Scholar 

  • Schmidt B, Ackermann R, Strohmeyer T (1995) Molecular biology of testicular germ cell tumors: current status. J Mol Med 73:355–367

    PubMed  CAS  Google Scholar 

  • Schmitz-Dräger BJ, van Roeyen CRC, Grimm M-O et al. (1994) p53 accumulation in precursor lesions lesions and early stages of bladder cancer. World J Urol 12:79–83

    PubMed  Google Scholar 

  • Schmitz-Dräger BJ, van Roeyen CRC, Gerharz C-D et al. (1995) p53 and c-myc during development and progression of bladder cancer. Eur Urol (eingereicht)

    Google Scholar 

  • Seizinger BR, Rouleau GA, Ozelius LJ et al. (1988) Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268–269

    PubMed  CAS  Google Scholar 

  • Serth J, Kuczyk MA, Bokemeyer C, Hervatin C, Nafe R, Tan HK, Jonas U (1995) p53 immuno-histochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br J Cancer 71:201–205

    PubMed  CAS  Google Scholar 

  • Shuin T, Kondo K, Torigoe S et al. (1994 a) Frequent somatic mutations and loss of heterozygosity of the Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852–2855

    PubMed  CAS  Google Scholar 

  • Shuin T, Misaki H, Kubota Y, Yao M, Hosaka M (1994b) Differential expression of protooncogenes in human germ cell tumors of the testis. Cancer 73:1721–1727

    PubMed  CAS  Google Scholar 

  • Shimizu M, Yokota J, Mori N et al. (1990) Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR. Oncogene 5:185 – 194

    PubMed  CAS  Google Scholar 

  • Shipman R, Schraml P, Colombi M, Raefle G, Ludwig CU (1993) Loss of heterozygosity on chromosome 11p 13 in primary bladder carcinoma. Hum Genet 91:455–458

    PubMed  CAS  Google Scholar 

  • Sidransky D, von Eschenbach A, Tsai YC et al. (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706–709

    PubMed  CAS  Google Scholar 

  • Sidransky D, Frost P, von Eschenbach A et al. (1992) Clonal origin of bladder cancer. New Engl J Med 326:737–740

    PubMed  CAS  Google Scholar 

  • Siegel D, Beall H, Senekowitsch C et al. (1992) Bioreductive activation of mitomycin C by DT-dia-phorase. Biochem 31:7879–7885

    CAS  Google Scholar 

  • Sikora K, Evan G, Stewart J, Watson JV (1985) Detection of the c-myc oncogene product in testicular cancer. Br J Cancer 52:171–176

    PubMed  CAS  Google Scholar 

  • Sitaras NM, Sariban E, Bravo M, Pantazis P, Antoniades HN (1988) Constitutive production of platelet-derived growth factor-like proteins by human prostate carcinoma cell lines. Cancer Res 48:1930–1935

    PubMed  CAS  Google Scholar 

  • Smeets W, Pauwels R, Laarakkers L, Debruyne F, Geraedts J (1987) Chromosomal analysis of bladder cancer. III. Nonrandom alterations. Cancer Genet Cytogenet 29:29–41

    PubMed  CAS  Google Scholar 

  • Solomon E, Voss R, Hall V, Rider SH (1987) Chromosome 5 allele loss in human colorectal carcinomas. Nature 328:616–619

    PubMed  CAS  Google Scholar 

  • Spruck III CH, Gonzalez-Zulueta M, Shibata A et al. (1994 a) p16 gene in uncultured tumours. Nature 370:183–184

    PubMed  Google Scholar 

  • Spruck III CH, Ohneseit PF, Gonzalez-Zulueta M et al. (1994 b) Two molecular pathways in transitional cell carcinoma of the bladder. Cancer Res 54:784–788

    PubMed  CAS  Google Scholar 

  • Stacey SN, Nielsen I, Skouv J, Hansen C, Autrup H (1990) Deregulation in trans of c-myc expression in immortalized human urothelial cells and in T24 bladder carcinoma cells. Mol Carcinogen 3:216–225

    CAS  Google Scholar 

  • Stadler WM, Sherman J, Bohlander SK et al. (1994) Homozygous deletions within chromosomal bands 9 p 21–22 in bladder cancer. Cancer Res 54:2060–2063

    PubMed  CAS  Google Scholar 

  • Strohmeyer T, Peter S, Hartmann M et al. (1991 a) Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res 51:1811–1816

    PubMed  CAS  Google Scholar 

  • Strohmeyer T, Reissmann P, Cordon-Cardo C et al. (1991b) Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci 88: 6662–6666

    PubMed  CAS  Google Scholar 

  • Strohmeyer T, Reese D, Press M et al. (1995) Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol 153:511–515

    PubMed  CAS  Google Scholar 

  • Suijkerbuijk RF, Sinke RJ, Olde Weghuis DEM et al. (1994) Amplification of chromosome subre-gion 12 p 11.2-p 12.1 in a metastasis of an I(12p)-negative seminoma: relationship to tumor progression. Cancer Genet Cytogenet 78:145–152

    PubMed  CAS  Google Scholar 

  • Suzuki H, Sato N, Watabe Y, Masai M, Seino S, Shimazaki J (1993) Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Molec Biol 46:759–765

    PubMed  CAS  Google Scholar 

  • Suzuki Y, Tamura G, Satodate R, Fujioka T (1992) Infrequent mutation of p 53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis. Jpn J Cancer Res 83:233–235

    PubMed  CAS  Google Scholar 

  • Tabin CJ, Bradley SM, Bargmann C et al. (1982) Mechamism of activation of a human oncogene. Nature 300:143–149

    PubMed  CAS  Google Scholar 

  • Takahashi R, Hashimoto T, Xu H-J et al. (1991) The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sci 88:5257–5261

    PubMed  CAS  Google Scholar 

  • Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenic regulator. Science 251: 1451–1455

    PubMed  CAS  Google Scholar 

  • Thoenes W, Störkel S, Rumpelt HJ (1986) Histopathology of renal cell tumors (adenomas, oncocytomas and carcinomas): the basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181:125–143

    PubMed  CAS  Google Scholar 

  • Tory K, Brauch H, Linehan M et al. (1989) Specific genetic changes in tumors associated with von Hippel Lindau disease. J Natl Cancer Inst 81:1097–1101

    PubMed  CAS  Google Scholar 

  • Trapman J, Sleddens HF, van der Weiden MM et al. (1994) Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54:6061–6064

    PubMed  CAS  Google Scholar 

  • Tsai YC, Nichols PW, Hiti AL, Williams Z, Skinner DG, Jones PA (1990) Allelic loss of chromosome 9, 11, and 17 in human bladder cancer. Cancer Res 50:44–47

    PubMed  CAS  Google Scholar 

  • Tsuura Y, Hiraki H, Watanabe K et al. (1994) Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dys-germinoma in human immunhistochemical study on formalin fixed, paraffin-embedded tissues. Virchows Archiv 424:135–141

    PubMed  CAS  Google Scholar 

  • Uchida T, Wada C, Wang, C, Egawa S, Ohtani H, Koshiba K (1994) Genomic instability of micro-satellite repeats and mutations of H-, K-, and N-ras, and p 53 genes in renal cell carcinoma. Cancer Res 54:3682–3685

    PubMed  CAS  Google Scholar 

  • Umbas R, Schalken JA, Aalders TW et al. (1992) Expression of the cellular adhesion molecule E-Cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52:5104–5109

    PubMed  CAS  Google Scholar 

  • Umbas R, Isaacs WB, Bringuier PB et al. (1994) Decreased E-Cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54:3929–3933

    PubMed  CAS  Google Scholar 

  • Vanni R, Scarpa RM (1986) Correspondence. Cancer Res 46:4873

    CAS  Google Scholar 

  • Varma VA, Austin GE, O’Connell AC (1989) Antibodies to ras oncogene p21 lack immunohistochemical specificity for neoplastic epithelium in human prostatic tissue. Arch Pathol Lab Med 113:16–19

    PubMed  CAS  Google Scholar 

  • Veldhuizen PI van, Sadasivan R, Garcia F, Austenfeld MS, Stephens RL (1993) Mutant p53 expression in prostate carcinoma. Prostate 22:23–30

    PubMed  Google Scholar 

  • Veldscholte J, Ris-Stalpers C, Kuiper GGJM et al. (1990) A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding chracteristics and response to anti-androgens. Biochem Biophys Res Comm 17:534–540

    Google Scholar 

  • Veldscholte J, Berrevoets CA, Brinkmann AO, Grootegoed JA, Mulder E (1992) Antiandrogens and the mutated androgen receptor of LNCaP cells: Differential effects on binding affinity, heat shock protein interaction, and transcription activation. Biochemistry 31:2393–2399

    PubMed  CAS  Google Scholar 

  • Vieweg J, Rosenthal FM, Bannerji R et al. (1994) Immunotherapy of prostate cancer in the Dunning rat model: Use of cytokine gene modified tumor vaccines. Cancer Res 54:1760–1765

    PubMed  CAS  Google Scholar 

  • Viola MV, Fromowitz F, Oravez S et al. (1986) Expression of ras oncogene p21 in prostate cancer. N Engl J Med 314:133–137

    PubMed  CAS  Google Scholar 

  • Visakorpi T, Kallioniemi O-P, Heikkinen A, Koivula T, Isola J (1992) Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J Natl Cancer Inst 84: 883–887

    PubMed  CAS  Google Scholar 

  • Visakorpi T, Hyytinen E, Koivisto P et al. (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Gen 9:401–406

    CAS  Google Scholar 

  • Vleminckx K, Vakaet JL, Mareel M, Fiers W, Van Roy F (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107–119

    PubMed  CAS  Google Scholar 

  • Vogelstein B, Fearon ER, Hamilton SR et al. (1988) Genetic alterations during colorectal tumor development. N Engl J Med 319:525–532

    PubMed  CAS  Google Scholar 

  • Wang L, Vass W, Gao C, Chang KSS (1987) Amplification and enhanced expression of the c-Ki-ras2 protooncogene in human embryonal carcinomas. Cancer Res 47:4192–4198

    PubMed  CAS  Google Scholar 

  • Wang N, Perkins KL (1984) Involvement of band 3p 14 in t (3; 8) hereditary renal cell carcinoma. Cancer Genet Cytogenet 11:479–481

    PubMed  CAS  Google Scholar 

  • Watson JV, Stewart J, Evan GI, Ritson A, Sikora K (1986) The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer. Br J Cancer 53:331–337

    PubMed  CAS  Google Scholar 

  • Weidner U, Peter S, Strohmeyer T, Hussnätter R, Ackermann R, Sies H (1990) Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma. Cancer Res 50:4504–4509

    PubMed  CAS  Google Scholar 

  • Werthman P, Drazan KE, Csete ME et al. (1994) Adenoviral-mediated transfer of human p 53 tumor suppressor gene to rat bladder in vivo. J Urol 151:389A

    Google Scholar 

  • Whartenby KA, Abboud CN, Marrogi AJ, Ramesh R, Freeman SM (1995) The biology of cancer gene therapy. Lab Invest 72:131–145

    PubMed  CAS  Google Scholar 

  • Wilding G, Chen M, Gelmann EP (1989) Aberrant response in vitro of hormone-responsive prostate cancer cells to antiandrogens. Prostate 14:103–115

    PubMed  CAS  Google Scholar 

  • Wood DP, Fair WR, Chaganti RSK (1992) Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer. J Urol 147:274–277

    PubMed  Google Scholar 

  • Wright C, Mellon K, Neal DE, Johnson P, Corbett I, Home CHW (1990) Expression of c-erbB-2 protein product in bladder cancer. Br J Cancer 62:764–765

    PubMed  CAS  Google Scholar 

  • Wright C, Mellon K, Johnston P et al. (1991) Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 63:967–970

    PubMed  CAS  Google Scholar 

  • Xu H-J, Cairns P, Hu S-X, Knowles MA, Benedict WF (1993) Loss of Rb expression in primary bladder cancer correlates with loss of heterozygosity at the Rb locus and tumor progression. Int J Cancer 53:781–784

    PubMed  CAS  Google Scholar 

  • Yamamoto T, Ikawa S, Akiyama T et al. (1986) Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature 319:230–234

    PubMed  CAS  Google Scholar 

  • Yoshida MA, Ohyashiki K, Ochi H et al. (1986) Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res 46:2139–2147

    PubMed  CAS  Google Scholar 

  • Zbar B, Tory K, Merino M et al. (1994) Hereditary papillary renal cell carcinoma. J Urol 151:561–566

    PubMed  CAS  Google Scholar 

  • Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ (1994 a) Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7 q 31.1. Cancer Res

    Google Scholar 

  • 54:6370–6373

    Google Scholar 

  • Zenklusen JC, Bieche I, Lidereau R, Conti CJ (1994 b) CA microsatellite repeat D7S522 is the most commonly deleted region in human breast cancer. Proc Natl Acad Sci 91:12155–12158

    Google Scholar 

  • Zenklusen JC, Barrett JC, Oshimura M, Conti CJ (1994 c) Inhibition of tumorigenicity of a murine squamous cell carcinoma (SCC) cell line by a putative tumor suppressor gene on human chromosome 7. Oncogene 9:2817–2825

    Google Scholar 

  • Zhau HE, Zhang X, von Eschenbach AC, Scorsone K, Babaian RJ, Ro JY, Hung M-C (1990) Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer. Mol Carcinogen 3:254–257

    CAS  Google Scholar 

Download references

Authors
  1. M.-O. Grimm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. J. Schmitz-Dräger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Urologische Klinik und Poliklinik, Medizinische Einrichtungen der Universität-GHS Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Herbert Rübben (Direktor der Urologischen Klinik und Poliklinik) (Direktor der Urologischen Klinik und Poliklinik)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Grimm, MO., Schmitz-Dräger, B.J. (1997). Molekularbiologie und Genetik urogenitaler Tumoren. In: Rübben, H. (eds) Uroonkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10731-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10731-7_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10732-4

  • Online ISBN: 978-3-662-10731-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation